by Strados Labs | Aug 28, 2025 | Press Releases
The pilot study explores the RESP® Biosensor’s potential to allow for low-effort home monitoring in patients with acute and chronic cystic fibrosis. Philadelphia, PA, August 28th, 2025 — Strados Labs, a digital health company advancing respiratory health through...
by Strados Labs | Aug 25, 2025 | Press Releases
Philadelphia, PA, August 25, 2025. Strados Labs, a medical technology company focused on improving surveillance of respiratory diseases, is proud to announce a series of ongoing research collaborations in 2025 with leading academic institutions across the United...
by Strados Labs | Jun 3, 2025 | Blog - Clinical Trial Focus
At this year’s ATS conference, Strados Labs was proud to host the session, “Tuning In To Cough in Pulmonary Fibrosis: How Should We Address the Gap?” presented by Dr. Toby Maher, Professor of Clinical Medicine at the Keck School of Medicine, USC. The talk focused on...
by Strados Labs | May 27, 2025 | Uncategorized
ATS 2025 Innovation Hub PresentationToby Maher, MD, PHD, Professor of Clinical Medicine at Keck School of Medicine, USC
by Strados Labs | May 1, 2025 | Events
Please join Strados Labs at ATS 2025 for an engaging session on the often-overlooked symptom of cough in pulmonary fibrosis, led by Dr Toby Maher, Professor of Clinical Medicine at Keck School of Medicine, USC. Tuning In To Cough In Pulmonary Fibrosis: How Should We...
